Charles T. Liamos

Charles T. Liamos is a declared insider of Insulet Corp, with filings sourced from SEC (Form 4). In total, 63 filings cover trades dated from 14 November 2008 to 1 April 2015.

In open-market terms, that means 8 purchases worth €22k on one side and 19 sales worth €7.8M on the other. Taken together, the sales exceed the purchases by €7.8M. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Other entries cover 14 share grants and 21 option exercises. So far in 2015, the count stands at no purchases and 4 sales.

A typical purchase (the median) is worth €2,051. Looking at 8 purchases old enough to measure, the stock rose over the following 90 days in 100% of cases; the median change was +149.2%. This is a record of the past, not a forecast.

On 3 April 2015 came the latest disclosure, a transaction in Insulet Corp. The clock since the last published purchase (19 March 2009) now reads 6,443 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.